Skip to main content

Table 1 Clinical and pathologic information of training set, test set and entire set

From: Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer

Character Training set Test set Entire set
Number % Number % Number %
Risk score
 Median 0.994441 0.843157 0.925682
 Range 0.074169–5.458149 0.186167–2.964505 0.074169–5.458149
Age
 Median 65 64 65
 Range 35–85 39–88 35–88
Gender
 Male 65 55.08 28 52.83 93 54.39
 Female 53 44.92 25 47.17 78 45.61
AJCC_stage
 I + II 112 94.92 52 98.11 164 95.91
 III + IV 6 5.08 1 1.89 7 4.09
Grade
 G1 + G2 88 74.58 33 62.26 121 70.76
 G3 + G4 30 25.42 20 37.74 50 29.24
T
 T1 + T2 20 16.95 10 18.87 30 17.54
 T3 + T4 98 83.05 43 81.13 141 82.46
N
 N0 + NX 37 31.36 13 24.53 50 29.24
 N1 81 68.64 40 75.47 121 70.76
M
 M0 + MX 115 97.46 52 98.11 167 97.66
 M1 3 2.54 1 1.89 4 2.34